Cenobamate is in clinical development as an adjunctive therapy for adults with primary
generalized tonic-clonic (PGTC) seizures. A generalised tonic-clonic seizure is the type of epileptic
seizure which is defined as a seizure that has a tonic phase (stiffening of the muscles) followed by
clonic muscle contractions (rhythmical jerking).
Cenobamate as an adjunctive therapy for primary generalised tonic-clonic seizures
Cenobamate is in clinical development as an adjunctive therapy for adults with primary generalized tonic-clonic (PGTC) seizures.
Interventions:
Cenobamate (YKP3089)
Indications:
Primary generalised tonic-clonic seizures
Therapeutic Areas:
Neurology
Year:
2022